Utah Asks Diabetes Patients to Share Insulin Costs for Its Lawsuit Against Insulin Makers and PBMs
Utah's Division of Consumer Protection is inviting current and past patients to describe buying and using diabetes medication over the past 10 years, to support the state's November 2023 lawsuit against insulin manufacturers, including Eli Lilly and Novo Nordisk, and pharmacy benefit managers, Utah News Dispatch reported via St. George News. The state says list prices of some insulins rose more than 1,000%. The companies deny the claims, and submissions may be subject to legal discovery.